Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(50%)

Phase Distribution

Ph phase_3
1
25%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(2)
Other(2)

Detailed Status

Terminated2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (50.0%)
Phase 41 (50.0%)

Trials by Status

terminated250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_3

Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration

NCT01786824
unknown

Hydration Status Assessment Through Body Composition Monitoring in Patients With Acute Myocardial Infarction

NCT02655341
unknown

Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)

NCT02388139
terminatedphase_4

Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation

NCT00445263

Clinical Trials (4)

Showing 4 of 4 trials
NCT01786824Phase 3

Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration

Terminated
NCT02655341

Hydration Status Assessment Through Body Composition Monitoring in Patients With Acute Myocardial Infarction

Unknown
NCT02388139

Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)

Unknown
NCT00445263Phase 4

Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation

Terminated

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4